- Home
- GRABW vs OCEAW Comparison
GRABW vs OCEAW Comparison
Compare GRABW & OCEAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRABW
- OCEAW
- Stock Information
- Founded
- GRABW 2012
- OCEAW N/A
- Country
- GRABW Singapore
- OCEAW United States
- Employees
- GRABW 10604
- OCEAW 7
- Industry
- GRABW Business Services
- OCEAW Biotechnology: Pharmaceutical Preparations
- Sector
- GRABW Consumer Discretionary
- OCEAW Health Care
- Exchange
- GRABW Nasdaq
- OCEAW Nasdaq
- Market Cap
- GRABW N/A
- OCEAW N/A
- IPO Year
- GRABW N/A
- OCEAW 2021
- Fundamental
- Price
- GRABW $0.46
- OCEAW $0.03
- Analyst Decision
- GRABW
- OCEAW
- Analyst Count
- GRABW 0
- OCEAW 0
- Target Price
- GRABW N/A
- OCEAW N/A
- AVG Volume (30 Days)
- GRABW 54.7K
- OCEAW N/A
- Earning Date
- GRABW 02-21-2025
- OCEAW N/A
- Dividend Yield
- GRABW N/A
- OCEAW N/A
- EPS Growth
- GRABW N/A
- OCEAW N/A
- EPS
- GRABW N/A
- OCEAW N/A
- Revenue
- GRABW $2,686,000,000.00
- OCEAW N/A
- Revenue This Year
- GRABW N/A
- OCEAW N/A
- Revenue Next Year
- GRABW N/A
- OCEAW N/A
- P/E Ratio
- GRABW N/A
- OCEAW N/A
- Revenue Growth
- GRABW 21.65
- OCEAW N/A
- 52 Week Low
- GRABW $0.15
- OCEAW N/A
- 52 Week High
- GRABW $0.59
- OCEAW N/A
- Technical
- Relative Strength Index (RSI)
- GRABW 46.43
- OCEAW N/A
- Support Level
- GRABW $0.36
- OCEAW N/A
- Resistance Level
- GRABW $0.51
- OCEAW N/A
- Average True Range (ATR)
- GRABW 0.09
- OCEAW 0.00
- MACD
- GRABW -0.02
- OCEAW 0.00
- Stochastic Oscillator
- GRABW 37.03
- OCEAW 0.00
About GRABW Grab Holdings Limited Warrant
Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore and Malaysia contributed 58% of revenue as of end-2021. Grab's main competitors in Southeast Asia are Foodpanda and Gojek, the ride-sharing arm of GoTo. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.
About OCEAW Ocean Biomediacal Inc.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.